FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Working on Pediatric Renal Function Models

CDER says its scientists are investigating how to improve pediatric dose selection by predicting drug clearance from renal function equations.

Medical Devices

FDA Software Functions Guidance Explained

Two Hyman, Phelps medical device technical experts review provisions in a new FDA draft guidance on medical device software premarket submissions.

House Covid Committee Wants Info from Hahn

The House Select Committee on Covid-19 asks former FDA commissioner Stephen Hahn for documents and an interview on Trump administration efforts to inj...

Human Drugs

Fast Track for Colorectal Cancer Folate Drug

FDA grants Isofol Medical a fast track designation for arfolitixorin, a stabilized and biologically active pure form of folate ([6R]-MTHF) for treatin...

FDA General

Califf Financial Disclosures Show Millions from Industry

New financial disclosure documents show Robert Califf earned millions of dollars last year from industry, which could disrupt the confirmation process...

Human Drugs

Groundbreaking Benefit/Risk Assessment Guidance Outlined

Four Sidley attorneys see significant regulatory change in a new FDA draft guidance on benefit/risk expectations for drug development, and they urge i...

Federal Register

FDA Reclassifies 3 Blood Lancets

Federal Register notice: FDA issues a final order to reclassify three types of blood lancets used to puncture skin to obtain a drop of blood for diagn...

Federal Register

Hep C Virus Antibody Assays Reclassified

Federal Register notice: FDA issues a final order to reclassify certain hepatitis C virus (HCV) antibody assay devices intended for the qualitative de...

Federal Register

Hep C virus RNA Devices Reclassified

Federal Register notice: FDA issues a final order to reclassify nucleic acid-based hepatitis C virus (HCV) ribonucleic acid (RNA) devices intended for...

Federal Register

Comments Extended on Sunscreen OTC Monograph

Federal Register notice: FDA extends the comment period for a 9/24 over-the-counter monograph proposed order until 12/27.